5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease

It was previously shown that a bodyweight reduction among patients with nonalcoholic fatty liver (NAFLD) was connected to the lower concentration of arachidonic and linoleic acid derivatives in their blood. We hypothesized that the concentration of these lipids was correlated with the extent of thei...

Descripción completa

Detalles Bibliográficos
Autores: Banaszczak, M. (Marcin)|||/items/339a98d4-81c9-4a29-ac84-b23106526156, Maciejewska, D. (Dominika)|||/items/9d778eb7-c02d-4392-a1a8-94eca4d2a662, Drozd, A. (Arleta)|||/items/1792207f-f306-47c8-ba95-f978e8e26c92, Ryterska, K. (Karina)|||/items/e9f82d46-e871-4493-be17-2afe175d6e66, Jamiol-Milc, D. (Dominika)|||/items/26a9cd1c-b24f-4127-af78-a6754432ddb7, Raszeja-Wyszomirska, J. (Joanna)|||/items/541b341f-083e-4e39-b388-b2624a9221a5, Wunsch, E. (Eva)|||/items/febe3385-7cd8-404d-af25-6be3c1c82954, Gonzalez-Muniesa, P. (Pedro)|||/items/3c8817f9-abc8-4a50-8bbd-68c967b4df48, Stachowska, E. (Ewa)|||/items/0fd8b662-097d-4316-a251-79602d758357
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universidad de Navarra
Repositorio:Dadun. Depósito Académico Digital de la Universidad de Navarra
Idioma:inglés
OAI Identifier:oai:dadun.unav.edu:10171/65194
Acceso en línea:https://hdl.handle.net/10171/65194
Access Level:acceso abierto
Palabra clave:Derivatives
Nonalcoholic fatty liver
Oxylipids
Steatosis
id ES_15f5dcdbe12f3d569e22479ebc80f99e
oai_identifier_str oai:dadun.unav.edu:10171/65194
network_acronym_str ES
network_name_str España
repository_id_str
spelling 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver DiseaseBanaszczak, M. (Marcin)|||/items/339a98d4-81c9-4a29-ac84-b23106526156Maciejewska, D. (Dominika)|||/items/9d778eb7-c02d-4392-a1a8-94eca4d2a662Drozd, A. (Arleta)|||/items/1792207f-f306-47c8-ba95-f978e8e26c92Ryterska, K. (Karina)|||/items/e9f82d46-e871-4493-be17-2afe175d6e66Jamiol-Milc, D. (Dominika)|||/items/26a9cd1c-b24f-4127-af78-a6754432ddb7Raszeja-Wyszomirska, J. (Joanna)|||/items/541b341f-083e-4e39-b388-b2624a9221a5Wunsch, E. (Eva)|||/items/febe3385-7cd8-404d-af25-6be3c1c82954Gonzalez-Muniesa, P. (Pedro)|||/items/3c8817f9-abc8-4a50-8bbd-68c967b4df48Stachowska, E. (Ewa)|||/items/0fd8b662-097d-4316-a251-79602d758357DerivativesNonalcoholic fatty liverOxylipidsSteatosisIt was previously shown that a bodyweight reduction among patients with nonalcoholic fatty liver (NAFLD) was connected to the lower concentration of arachidonic and linoleic acid derivatives in their blood. We hypothesized that the concentration of these lipids was correlated with the extent of their body mass reduction and, thus, liver steatosis. Methods: We analyzed 68 individuals who completed the dietary intervention. Patients were divided into two groups depending on their body mass reduction (more or less than 7%). Before and after the dietary intervention, all patients had the following measurements recorded: body mass, waist circumference, stage of steatosis, fatty liver index, liver enzymes, lipid parameters, insulin and glucose. Concentrations of lipoxins A4 (LTX A4), hydroxyeicosatetraenoic fatty acids (5(S)-HETE, 12(S)-HETE and 16(S)-HETE), hydroxyoctadecaenoic acids (9(S)-HODE and 13(S)-HODE) and 5-oxo-eicosatetraenoic acid (5-oxo-ETE) were measured in serum samples collected before and after the dietetic intervention using high-performance liquid chromatography (HPLC). Results: Patients who reduced their body mass by more than 7% revealed a significant improvement in their steatosis stage, waist circumference, fatty liver index, triglycerides and cholesterol. Conclusion: A reduction in body mass by more than 7% but not by less than 7% revealed a significant improvement in steatosis stage; waist circumference; fatty liver index; and levels of triglycerides, cholesterol, 5-oxo-ETE and LTXA-4.MDPIDadun. Depósito Académico Digital Universidad de Navarra20232023-01-3020202020-01-0120202020-01-01journal articlehttp://purl.org/coar/resource_type/c_6501info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10171/65194reponame:Dadun. Depósito Académico Digital de la Universidad de Navarrainstname:Universidad de NavarraInglésengopen accesshttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessoai:dadun.unav.edu:10171/651942026-06-21T12:47:57Z
dc.title.none.fl_str_mv 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
title 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
spellingShingle 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
Banaszczak, M. (Marcin)|||/items/339a98d4-81c9-4a29-ac84-b23106526156
Derivatives
Nonalcoholic fatty liver
Oxylipids
Steatosis
title_short 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
title_full 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
title_fullStr 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
title_full_unstemmed 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
title_sort 5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
dc.creator.none.fl_str_mv Banaszczak, M. (Marcin)|||/items/339a98d4-81c9-4a29-ac84-b23106526156
Maciejewska, D. (Dominika)|||/items/9d778eb7-c02d-4392-a1a8-94eca4d2a662
Drozd, A. (Arleta)|||/items/1792207f-f306-47c8-ba95-f978e8e26c92
Ryterska, K. (Karina)|||/items/e9f82d46-e871-4493-be17-2afe175d6e66
Jamiol-Milc, D. (Dominika)|||/items/26a9cd1c-b24f-4127-af78-a6754432ddb7
Raszeja-Wyszomirska, J. (Joanna)|||/items/541b341f-083e-4e39-b388-b2624a9221a5
Wunsch, E. (Eva)|||/items/febe3385-7cd8-404d-af25-6be3c1c82954
Gonzalez-Muniesa, P. (Pedro)|||/items/3c8817f9-abc8-4a50-8bbd-68c967b4df48
Stachowska, E. (Ewa)|||/items/0fd8b662-097d-4316-a251-79602d758357
author Banaszczak, M. (Marcin)|||/items/339a98d4-81c9-4a29-ac84-b23106526156
author_facet Banaszczak, M. (Marcin)|||/items/339a98d4-81c9-4a29-ac84-b23106526156
Maciejewska, D. (Dominika)|||/items/9d778eb7-c02d-4392-a1a8-94eca4d2a662
Drozd, A. (Arleta)|||/items/1792207f-f306-47c8-ba95-f978e8e26c92
Ryterska, K. (Karina)|||/items/e9f82d46-e871-4493-be17-2afe175d6e66
Jamiol-Milc, D. (Dominika)|||/items/26a9cd1c-b24f-4127-af78-a6754432ddb7
Raszeja-Wyszomirska, J. (Joanna)|||/items/541b341f-083e-4e39-b388-b2624a9221a5
Wunsch, E. (Eva)|||/items/febe3385-7cd8-404d-af25-6be3c1c82954
Gonzalez-Muniesa, P. (Pedro)|||/items/3c8817f9-abc8-4a50-8bbd-68c967b4df48
Stachowska, E. (Ewa)|||/items/0fd8b662-097d-4316-a251-79602d758357
author_role author
author2 Maciejewska, D. (Dominika)|||/items/9d778eb7-c02d-4392-a1a8-94eca4d2a662
Drozd, A. (Arleta)|||/items/1792207f-f306-47c8-ba95-f978e8e26c92
Ryterska, K. (Karina)|||/items/e9f82d46-e871-4493-be17-2afe175d6e66
Jamiol-Milc, D. (Dominika)|||/items/26a9cd1c-b24f-4127-af78-a6754432ddb7
Raszeja-Wyszomirska, J. (Joanna)|||/items/541b341f-083e-4e39-b388-b2624a9221a5
Wunsch, E. (Eva)|||/items/febe3385-7cd8-404d-af25-6be3c1c82954
Gonzalez-Muniesa, P. (Pedro)|||/items/3c8817f9-abc8-4a50-8bbd-68c967b4df48
Stachowska, E. (Ewa)|||/items/0fd8b662-097d-4316-a251-79602d758357
author2_role author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Dadun. Depósito Académico Digital Universidad de Navarra
dc.subject.none.fl_str_mv Derivatives
Nonalcoholic fatty liver
Oxylipids
Steatosis
topic Derivatives
Nonalcoholic fatty liver
Oxylipids
Steatosis
description It was previously shown that a bodyweight reduction among patients with nonalcoholic fatty liver (NAFLD) was connected to the lower concentration of arachidonic and linoleic acid derivatives in their blood. We hypothesized that the concentration of these lipids was correlated with the extent of their body mass reduction and, thus, liver steatosis. Methods: We analyzed 68 individuals who completed the dietary intervention. Patients were divided into two groups depending on their body mass reduction (more or less than 7%). Before and after the dietary intervention, all patients had the following measurements recorded: body mass, waist circumference, stage of steatosis, fatty liver index, liver enzymes, lipid parameters, insulin and glucose. Concentrations of lipoxins A4 (LTX A4), hydroxyeicosatetraenoic fatty acids (5(S)-HETE, 12(S)-HETE and 16(S)-HETE), hydroxyoctadecaenoic acids (9(S)-HODE and 13(S)-HODE) and 5-oxo-eicosatetraenoic acid (5-oxo-ETE) were measured in serum samples collected before and after the dietetic intervention using high-performance liquid chromatography (HPLC). Results: Patients who reduced their body mass by more than 7% revealed a significant improvement in their steatosis stage, waist circumference, fatty liver index, triglycerides and cholesterol. Conclusion: A reduction in body mass by more than 7% but not by less than 7% revealed a significant improvement in steatosis stage; waist circumference; fatty liver index; and levels of triglycerides, cholesterol, 5-oxo-ETE and LTXA-4.
publishDate 2020
dc.date.none.fl_str_mv 2020
2020-01-01
2020
2020-01-01
2023
2023-01-30
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10171/65194
url https://hdl.handle.net/10171/65194
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Dadun. Depósito Académico Digital de la Universidad de Navarra
instname:Universidad de Navarra
instname_str Universidad de Navarra
reponame_str Dadun. Depósito Académico Digital de la Universidad de Navarra
collection Dadun. Depósito Académico Digital de la Universidad de Navarra
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869403828167639040
score 15.300719